Haloxazolam is a GABA-A receptor agonist indicated for the treatment of anxiety. The drug is approved and marketed in Japan under the name Somelin.

Haloxazolam:
https://drugs.ncats.io/drug/M448L2V8XP

Haloxazolam Monograph:
http://www.inchem.org/documents/pims/pharm/pim927.htm

Haloxazolam (marketed in Japan under the brand name Somelin), is a drug which is a benzodiazepine derivative. It has similar hypnotic properties as the benzodiazepine drugs triazolam, temazepam, and flunitrazepam and as such is indicated for the treatment insomnia.